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Abstract 
Background: Majority of enteric infections are foodborne and antimicrobials including antibiotics have been used 
for their control and treatment. However, probiotics or prebiotics or their combination offer a potential alternative 
intervention strategy for improving the host health and preventing foodborne pathogen colonization/infections in 
reservoir. Further, bioengineered probiotics expressing bioactive products to achieve specific function is highly desir-
able. Recently, we over-expressed mcra (myosin cross-reactive antigen) gene in Lactobacillus casei (Lc) and developed 
a bioengineered probiotics Lc + CLA which produce higher amounts of metabolites including conjugated linoleic 
acid (CLA). Furthermore, we also reported that prebiotic like components such as berry pomace (byproduct) phenolic 
extracts (BPEs) can enhance the growth of probiotics and improved the beneficial effects of probiotics. In this study, 
we evaluated the antimicrobial effect of modified Lc + CLA in combination of BPEs on growth, survival and pathogen-
esis of enterohemorrhagic Escherichia coli (EHEC).
Results: In mixed culture condition, the growth of EHEC was significantly reduced in the presence Lc + CLA and/or 
BPEs. Cell-free cultural supernatant (CFCS) collected from Lc or Lc + CLA strain also inhibited the growth and survival 
of EHEC and the inhibitory effects of CFCSs against EHEC were enhanced in the presence of BPEs in concentration 
dependent manner. Interaction between EHEC and intestinal epithelial INT-407 cells were also altered significantly in 
the presence of either Lc or Lc + CLA strain or their CFCSs with or without BPEs. The expression of multiple virulence 
genes and physicochemical properties of EHEC were also altered when the bacterial cells were pretreated with CFCSs 
and/or BPEs.
Conclusions: These results showed that diet containing bioactive Lc + CLA and natural prebiotic like component 
such as BPEs might be an effective way to prevent foodborne infections with EHEC.
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Background
Majority of enteric infections are foodborne and, in most 
case, bacteria are the major pathogenic agents followed 
by viruses, and then parasites. Among the enteric bac-
terial pathogens, Enterohemorrhagic Escherichia coli 
(EHEC) is one of the pre-dominants enteric bacterial 
pathogen in the USA and other developed countries. 
EHEC is frequently isolated from beef and other food 
products such as produce as well as recorded as a top 
ranked foodborne bacterial pathogenic agents in respect 
to mortality and morbidity [1, 2]. Enteric infection with 
EHEC also can lead to kidney failure due to the severe 
cytotoxic effect of EHEC known as Hemolytic Uremic 
Syndrome (HUS) [1]. This effect could be intensified 
due to the antibiotic therapy [2]. In addition, with high 
incidence of antibiotic resistance in EHEC [3], the devel-
opment of novel bio-therapeutics against this specific 
enteric bacterial pathogen, is more crucial than ever.
Probiotic, as predominate part of gut microbial eco-
system, plays critical roles in maintaining the balance of 
human GI ecosystems and prevent the enteric infections 
by limiting colonization of enteric pathogen [4–6]. In 
addition, with host health promotion, probiotics showed 
several defensive or beneficial activities against patho-
gens including competitive exclusion, inhibition of bacte-
rial protein synthesis, limiting quorum sensing, secretion 
of proteins, and their motility/mobility [4–8]. However, 
all these beneficial roles of probiotics against enteric bac-
terial pathogens generally depend on the ratio of probi-
otic within the gut ecosystems and the total amount of 
bioactive metabolites specifically short chain fatty acids 
and other acids produced by them.
On the other hand, the use of dietary plant phenolic 
extracts is becoming an attractive alternative therapy 
[9–11]. Fruit byproducts, especially blackberry (Rubus 
fruticosus) and blueberry (Vaccinium corymbosum) 
byproducts commonly known as pomace, contain bioac-
tive phenolics including flavan, flavanone, flavones, glu-
curonides, glucosides, quinolones, catechol, coumarin, 
phenols, luteolines, tannins, quercetin, chlorogenic 
acid, ellagic acid, gallic acid, xanthoxic acid [12]. Recent 
reports have shown that berry pomace phenolic extracts 
(BPEs) are antimicrobial against a wide variety of enteric 
bacterial pathogens [13–16] and in the presence of BPEs, 
growth of beneficial bacterial/probiotic is enhanced 
with increased production of the bioactive metabolites 
[17–20].
Combination of probiotic and prebiotic, known as syn-
biotics, have emerged as a promising alternative treat-
ment approach and can improve and maintain host 
health; beneficial effects depend largely upon the total 
quantity of probiotics and the amount and type of func-
tional byproducts (proteins and peptides) they produce. 
In a recent study, we found that in the presence of the 
prebiotic-like component peanut flour, Lactobacillus 
casei (Lc) produced 100 times more linoleic acid (LA) 
than under normal condition and was able to outcom-
pete several enteric bacterial pathogens [13, 21, 22]. On 
the basis of such observation, we have overexpressed 
the linoleate isomerase (myosin cross-reactive antigen, 
mcra) gene in a natural, sustainable Lc strain in order 
to enhance the production of conjugated linoleic acids 
(CLA) [23, 24] and verify the ability of this genetically 
engineered strain (Lc + CLA) to inhibit growth and infec-
tion of host cells by EHEC in vitro.
In this study, we assess the effect of genetically modified 
L. casei with increased production ability of CLA, known 
as Lc + CLA in combination with various concentration 
of BPEs against the growth and survival ability EHEC and 
its interaction with cultured human intestinal epithelial 
(INT-407) cells. Further, we also compare expression 
levels of EHEC virulence mediatory genes, and phys-
icochemical properties in the presence or absence of the 
probiotic strains and/or bioactive phenolic extracts.
Results
Growth inhibition of EHEC in presence or absence 
of probiotic strains and/or pomace phenolic extracts
To determine the effect of prebiotic like component 
BPEs, probiotic strain Lc or Lc + CLA or the metabolites 
produced by Lc or Lc + CLA in CFCSs on the growth 
inhibition of EHEC, we co-cultured EHEC with Lc or 
Lc + CLA or their CFCSs with different concentrations of 
BPEs [0.1 mg/ml gallic acid equivalent (GAE) or 0.5 mg/
ml GAE or 1.0  mg/ml GAE]. In the presence of BPEs 
either of 0.1 mg/ml GAE or 0.5 mg/ml GAE, the growth 
of EHEC was not significantly reduced compared to the 
control but when the concentration of BPE was raised to 
1.0  mg/ml GAE, the growth of EHEC was reduced sig-
nificantly within 24 h (Fig. 1A–C). Further, either probi-
otic strain, Lc or Lc + CLA in combination with 0.1 mg/
ml GAE or 0.5  mg/ml GAE or 1.0  mg/ml GAE of BPEs 
intensified the reduction of the growth of EHEC in a time 
dependent manner but the inhibitory effect of Lc + CLA 
in presence of 1.0 mg/ml GAE was observed at maximum 
level [> 8.0 logs colony forming unit (CFU)/ml reduction] 
than the other treatments (Fig. 1C). CFCS collected from 
of Lc (CFCS-Lc) or Lc + CLA (CFCS-Lc + CLA) in the 
presence of BPEs of different concentrations also showed 
inhibitory effects on the growth of EHEC (Fig.  1A–C). 
After 24  h, the reduction in the growth of EHEC was 
observed ranging from < 1.0 log CFU/ml (CFCS-Lc in 
presence of 0.1  mg/ml GAE of BPE) to > 3.0 logs CFU/
ml (CFCS-Lc + CLA in presence of 1.0  mg/ml GAE 
of BPE). After 48  h of incubation, the growth of EHEC 
was reduced more than 3.0 logs CFU/ml by CFCS-Lc 
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Fig. 1 Growth pattern of EHEC (A–C) at various time (24, 48, and 72 h) points with or without treatments. Error bars indicate standard deviation 
from 6 parallel trails. Different letters (a–f ) at each time point indicate the significant growth reduction when compared with single culture as a 
control and among the treatments at p < 0.05
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in presence of 1.0  mg/ml GAE of BPEs and more than 
4 logs CFU/ml by CFCS-Lc + CLA in presence of BPEs 
of 1.0  mg/ml GAE concentration compared to control 
group (no CFCS or BPEs added to the growth medium). 
After 72  h of incubation, the most effective growth 
reduction of EHEC was observed by CFCS-Lc + CLA in 
presence of 1.0 mg/ml GAE of BPEs with no detectable 
growth (Fig. 1C).
Alteration of EHEC adhesion ability in cultured mammalian 
cells
The adhesion ability of EHEC to INT-407 cells in the 
presence of different concentrations (0.1 mg/ml GAE or 
0.5  mg/ml GAE or 1.0  mg/ml GAE) of BPEs, in combi-
nation with Lc or Lc + CLA itself or their metabolites 
containing CFCSs (CFCS-Lc and CFCS-Lc + CLA) was 
reduced significantly from 0.5 log CFU/ml to 4.0 logs 
CFU/ml (Fig. 2A–C). BPEs (0.1 mg/ml GAE or 0.5 mg/ml 
GAE) without the probiotics or their CFCSs, numerically 
reduced the adhesion ability, though 1.0  mg/ml GAE 
reduced adhesion ability around 0.6 log CFU/ml, signifi-
cantly (Fig.  2A–C) when compared to the control (only 
medium without any treatments).
Alteration of EHEC physicochemical properties in presence 
of BPEs and/or CFCSs collected from Lc or Lc + CLA
We observed that pre-treatments of EHEC with all the 
treatments accept 0.1  mg/ml GAE of BPE, significantly 
increased the percentage of injured bacterial cells ranging 
from 36.33 to 58.97% when compared to control (with-
out any treatments in growth media) (Table 1). The auto-
aggregation capacity of EHEC decreased significantly by 
CFCS-Lc in presence of 1.0 mg/ml GAE of BPE or CFCS-
Lc + CLA in presence of 0.5  mg/ml GAE or 1.0  mg/
ml GAE of BPEs, and CFCS-Lc + CLA in presence of 
1.0 mg/ml GAE of BPE was the most effective when com-
pared to control group. The auto-aggregation capacity of 
EHEC was reduced numerically by 0.1 or 0.5 or 1.0 mg/
ml GAE of BPE, CFCS-Lc in presence of 0.1 mg/ml GAE 
or 0.5 mg/ml GAE of BPE, CFCS-Lc + CLA in presence 
of 0.1 mg/ml of GAE but not significantly (Table 1). We 
also found that cell surface hydrophobicity of EHEC was 
reduced significantly with all the pre-treatments ranging 
from 4.65 to 1.45% accept 0.1 mg/ml GAE of BPE. Also, 
BPE of 0.1  mg/ml GAE concentration reduced the cell 
surface hydrophobicity of EHEC to 13.1% when com-
pared to control group but only numerically (Table 1).
Disruption of biofilm formation of EHEC with BPEs and/
or CFCSs collected from Lc or Lc + CLA
Biofilm formation is the process of attachment to a sur-
face which can affect the growth rate and gene transcrip-
tion ability of a bacteria and when EHEC was incubated 
in presence of BPEs (0.1 mg/ml GAE or 0.5 mg/ml GAE 
or 1.0 mg/ml GAE) without CFCSs (collected from over-
night culture of Lc or Lc + CLA) the biofilm formation 
ability was reduced significantly around 1.0 log CFU/ml. 
BPEs in combination with CFCS-Lc or CFCS-Lc + CLA 
also reduced the biofilm formation ability of EHEC when 
compared to the control group (growth media without 
treatment), significantly from < 1.0 log CFU/ml to > 4.4 
logs CFU/ml and CFCS-Lc + CLA was more effective 
in the reduction of the biofilm formation in presence of 
same concentration of BPE in comparison with CFCS-Lc 
(Fig. 3A).
Effect of CFCSs collected from Lc or Lc + CLA 
with or without BPEs on EHEC virulence gene expression
Expression of espA gene of EHEC, which is responsible 
for encoding secreted protein related to signal transduc-
tion leading to A/E lesion formation, was significantly 
down-regulated at a range from 1.2- to 62.5-folds by 
either CFCS-Lc or CFCS-Lc + CLA collected from Lc or 
Lc + CLA in the presence of different concentrations of 
BPEs (Fig. 4a–c). The expression level of espB and espD 
genes which are also involved in signal transduction lead-
ing to A/E lesion formation were down regulated sig-
nificantly ranging from 1.1- to 28-folds in the treatment 
assay. The expression level of eaeA encoding intimin 
protein required for intimate attachment was also down 
regulated significantly more than 1.1-folds to more than 
3.9-folds in the assay. The expression level of locus of 
enterocyte effacement (LEE)-encoded regulator, ler was 
downregulated significantly > 1.3- to > 8.5-folds by all 
the concentrations of BPEs with or without CFCS-Lc or 
CFCS-Lc + CLA. The expression level of tir responsible 
for translocated intimin receptor was also downregulated 
around onefold by different concentrations of BPEs with 
or without CFCS-Lc or CFCS-Lc + CLA (Fig. 4a–c).
Discussions
In this study, the combined effect of Lc + CLA, the pro-
biotic strain with enhanced ability of conjugated linoleic 
acid (CLA) production, and bioactive phenolic com-
pounds, BPEs extracted from blackberry and blueberry 
pomaces (byproducts), on the growth, survival and phys-
icochemical properties of EHEC and in alteration of its 
interactions with human intestinal epithelial (INT-407) 
cells was investigated. BPE which showed its anti-oxida-
tion and modulation ability of gut microbiome positively 
in our previous chicken trial [25], was tested in this study 
to amplify the beneficial effects of Lc or Lc + CLA.
We observed the synergistic effect of Lc or Lc + CLA 
and BPEs enhance the inhibiting ability of the growth 
of EHEC but the effect of BPE depends on concentra-
tion and duration of treatment period. These findings 
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Fig. 2 Adhesion of EHEC to INT-407 cells with or without pre-treatments (A–C) with probiotics (Lc or Lc + CLA) and their metabolites in CFCSs. Error 
bars indicate standard deviation from 6 parallel trails. Bars with different letters (a through d) are significantly different when compared with control 
and among the treatments at p < 0.05
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satisfy the previous reports in which we observed that 
CLA overproducing strain, Lc + CLA and its metabo-
lites containing CFCSs could alter the pathogenesis of 
several enteric bacterial pathogens including EHEC, Sal-
monella and Campylobacter jejuni [23, 24]. It has been 
also reported that CLA improved host gut health and 
immunity by protecting against inflammation and also 
play important role in metabolic pathways and in balanc-
ing gut microbial ecosystem [26, 27]. Further, researchers 
have reported that secondary plant metabolites contain-
ing bioactive phenolic extracts possess antimicrobial and 
anti-oxidant properties [28, 29]. In our laboratory, we also 
found that phenolic extracts from blueberry and black-
berry pomace could inhibit the growth and survival of 
various enteric bacterial pathogens including Salmonella 
and Campylobacter and altered the virulence properties 
of these pathogens and their interaction with host cells 
[12, 15, 30]. In our in vivo study, we also found that BPE 
can reduce the colonization of enteric bacterial pathogen 
Campylobacter in chicken gut on concentration depend-
ent manners and a very trace amount (0.1 GAE mg/ml) 
of BPEs also act as a growth promoter in chicken [31]. In 
this study, we found the combined effects CLA over-pro-
ducing Lactobacillus strain with various concentration 
of BPEs can inhibit the growth and alter different patho-
genic traits of EHEC at higher efficacy compared to BPEs 
at the same concentration alone.
In this current study, we also observed that CFCSs 
collected from either Lc or Lc + CLA could modify the 
growth and pathogenesis of EHEC and effect of CFCSs 
on EHEC growth reduction may not only depend on 
medium acidification, as growth of EHEC at a wide range 
of pH was previously observed [32]. As anti-pathogenic 
traits of phenolic compounds and Lc + CLA along with 
other metabolites in CFCSs showed an intensive effect on 
EHEC, it can be inferred that both metabolites produced 
by Lc or Lc + CLA and bioactive phenolic components of 
berry pomace could act synergistically, also found previ-
ously [33].
As attachment is considered to be important virulence 
properties, in this study we observed that adhesion effi-
cacy of EHEC was reduced significantly in cultured mam-
malian intestinal epithelial cells, INT-407 in co-culture 
with Lc or Lc + CLA or treated by the CFCSs obtained 
from overnight culture of Lc or Lc + CLA in presence of 
BPEs. Higher concentrations of BPEs alone could reduce 
the adhesion efficacy significantly compared to growth 
media without any supplement. It has been reported 
before that similar carbohydrate-binding specific pro-
teins are displayed on Lactobacillus spp. surface and may 
involve in decreasing the adhesiveness of enteric bacte-
rial pathogens by pre-occupying the surface receptors 
on host cells [34]. Researchers have also reported that 
CFCSs, collected from various condition of Lactobacil-
lus spp. also restricted the cells adhesion to host epithe-
lial cells by different enteric bacterial pathogens [4, 35]. 
To further investigate the attenuated bacterial virulence 
at gene expression level, we observed that the expres-
sion level of different virulence genes. The ler is the main 
transcriptional regulator for EHEC that modulates all 
effectors especially espA, espB, espD, eaeA and tir for 
attaching and effacing of the bacteria [36, 37] and were 
down regulated in the presence of the treatments of this 
study. This finding indicated that the down-regulation 
of the transcriptional regulator repressed the expression 
of effector genes for bacterial attachment, and therefore 
directly related to the reduction of EHEC-host cell inter-
actions and other pathogenicity related traits.
Several groups of researchers reported positive relation 
among hydrophobicity, auto-aggregation and cell asso-
ciation activities [38–40]. In this study, combined treat-
ments with CFCSs from Lc/Lc + CLA in presence of BPEs 
Table 1 Physicochemical properties of EHEC treated with BPEs/CFCSs collected from overnight culture of Lc/Lc + CLA
*Values indicate mean ± standard deviation and means with different letters (a–c) within the same column are different when compared with control and among the 
treatments at p < 0.05
Treatment Auto-aggregation (%) Hydrophobicity (%) Injured cell (%)
Control 5.89 ± 1.47*,a 13.1 ± 2.16a 16.52 ± 5a
0.1 mg/ml GAE 5.38 ± 1.61a 9.87 ± 2.52ab 26.84 ± 5.07ab
0.1 mg/ml GAE + CFCS-Lc 4.65 ± 2.7a 8.28 ± 2.49bc 41.4 ± 5.57bc
0.1 mg/ml GAE + CFCS-Lc + CLA 2.91 ± 1.52ab 4.57 ± 2.06bc 50.35 ± 3.93c
0.5 mg/ml GAE 4.45 ± 1.34a 8.38 ± 1.98b 36.33 ± 6.06b
0.5 mg/ml GAE + CFCS-Lc 3.41 ± 1.56a 6.85 ± 1.77bc 45.9 ± 4.77bc
0.5 mg/ml GAE + CFCS-Lc + CLA 2.18 ± 1.21b 3.5 ± 1.2dc 53.2 ± 7.01c
1.0 mg/ml GAE 3.69 ± 0.86a 6.36 ± 1.74bc 45.34 ± 5.42bc
1.0 mg/ml GAE + CFCS-Lc 2.78 ± 1.41b 4.8 ± 1.54c 49.92 ± 6.47bc
1.0 mg/ml GAE + CFCS-Lc + CLA 1.45 ± 0.02b 2.89 ± 1.14c 58.97 ± 3.45c
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resulted in decreased hydrophobicity and auto-aggrega-
tion, which might impact on the reduction of adhesive-
ness in EHEC into INT-407 cells [12, 22, 41]. We also 
observed deferred ability of biofilm formation by EHEC 
with the combined treatments of CFCSs collected from 
either Lc or Lc + CLA in presence of different concentra-
tions of BPEs. A positive association between bacterial 
auto-aggregation, cell surface hydrophobicity to biofilm 
formation ability has also been reported previously and 
our findings agreed with other study [42]. Injured but 
viable EHEC cell percentage was increased significantly 
by all the treatments and the effect intensified with the 
higher concentrations of BPEs or higher concentrations 
of bioactive metabolites, as higher concentration of BPEs 
were more efficient or CFCS from Lc + CLA was more 
effective compared to CFCS from Lc in presence of the 
same concentration of BPE. We hypothesized that the 
ratio of injured bacterial cells depends on the anti-patho-
genic metabolites present in the treatments.
Conclusion
Probiotics specifically linoleic acid over-producing Lacto-
bacillus strain, Lc + CLA, in the presence of BPEs exhib-
ited rigorous effects on EHEC pathogenesis. Further, the 
growth medium supplemented with trace amount of 
BPEs stimulated the growth of probiotic strains [33], and 
also intensified the inhibitory effect of CFCSs collected 
from Lc + CLA on growth and survival of EHEC and 
altered the INT-407 cells-EHEC interactions. The prom-
ising roles of the combination of the genetically engi-
neered probiotic strain, Lc + CLA and bioactive BPEs in 
controlling foodborne infection with EHEC, particularly 
growth inhibition, physicochemical properties alteration, 
disruption of EHEC-host cell interactions, and its viru-
lence genes suppression indicated the possibility to make 
this synbiotic potential alternative to preventive and/
or therapeutics for EHEC infection in human. In future, 
the effectiveness of the synbiotic is needed to confirm in 
appropriate animal model.
Materials and method
Bacterial strains and growth conditions
In this study, enterohemorrhagic Escherichia coli 
EDL933 (EHEC) (ATCC 700927) was grown on Luria-
Bertani (LB) agar (EMD Chemicals Inc., USA) for 18  h 
at 37  °C under aerobic conditions (Thermo Fisher Sci-
entific Inc., USA). Probiotic strains, Lactobacillus casei 
(Lc) (ATCC 334) and lineolate over-expressed bioac-
tive L. casei (Lc + CLA) [23, 24] were grown on de Man 
Rogosa Sharpe (MRS) agar (EMD Chemicals Inc., USA) 
overnight at 37 °C under aerobic condition with 5%  CO2 
(Thermo Fisher Scientific Inc., USA).
Preparation of pomace phenolic extracts
Commercial blackberry and blueberry pomaces was 
donated by Milne Fruit Products Inc., Prosser, WA, USA, 
and BPE was extracted following the protocol previously 
reported [13]. Spectrophotometric method was used to 
measure the concentration of BPE and expressed as GAE 
[43]. BPE was comprised of blackberry and blueberry 
pomace extracts at 1:1 v/v ratio for this study.
Fig. 3 Biofilm formation pattern of EHEC (A–C) treated with BPEs 
alone or CFCSs collected from Lc or Lc + CLA grown in the presence 
of BPEs. Error bars indicate standard deviation from 6 parallel trails. 
Different letters (a–d) indicate the significant reduction in biofilm 
formation when compared with control and among the treatments 
at p < 0.05
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Fig. 4 Relative expression of different virulence genes of EHEC (a–c) treated with BPEs alone or CFCSs collected from Lc or Lc + CLA grown in 
the presence of BPEs (0.1 mg/ml GAE or 0.5 mg/ml GAE or 1.0 mg/ml GAE). Error bars indicate standard deviation from 6 parallel trails. Bars with 
different number of asterisks (*) are significantly different at p < 0.05
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Mammalian cell and culture conditions
Human intestinal epithelial (INT-407) (ATCC CCL-6) 
cells were cultured at 37 °C, standard condition (5%  CO2) 
in Dulbecco’s Modified Eagle Medium (DMEM) (Corn-
ing Cellgro, USA) supplemented with 10% heat-inacti-
vated Fetal Bovine Serum (FBS) (Corning Cellgro, USA) 
and 50  µg/ml of gentamycin (Lonza, USA). For mon-
olayer preparation, INT-407 cells were seeded in 24-well 
culture plate (Greiner Bio-one Inc., USA) at 2 × 105 
cells/ml and maintained following the standard protocol 
described as above to form > 90% confluence monolayer. 
Before use, the monolayers were washed with phosphate 
buffer saline (PBS) three times and immersed in antibi-
otic free DMEM supplemented with 5% heat-inactivated 
FBS [24].
Cell free culture supernatant
Cell free culture supernatant (CFCS) of overnight liquid 
cultures of Lc, and Lc + CLA were collected following the 
method previously reported by our laboratory [21] and 
collected CFCSs were filtered and stored at 4 °C.
Growth inhibition assay
Inhibition of EHEC growth was carried out in presence 
of different concentrations of BPEs (0.1  mg/ml GAE 
or 0.5  mg/ml GAE or 1.0  mg/ml GAE) and/or Lc or 
LC + CLA. All bacterial strains were grown on selective 
respective agar plates following the method described 
above. A volume of 400  µl of Lc or Lc + CLA bacterial 
suspension containing approximately  107  CFU/ml was 
mixed with equal volume of EHEC suspension contain-
ing approximately  106 CFU/ml in 3.2 ml of LB broth and 
incubated at 37 °C in presence of different concentrations 
(0.1 mg/ml GAE or 0.5 mg/ml GAE or 1.0 mg/ml GAE) 
of BPE. Serial dilutions were performed in PBS, followed 
by plating on LB agar for EHEC at 0, 24, 48, and 72 h time 
points. For inhibition assay with CFCSs, instead of live Lc 
or Lc + CLA, 400 µl of CFCS-LC (collected from Lc) or 
CFCS-Lc + CLA (collected from Lc + CLA) with/without 
BPEs were mixed with equal volume of EHEC suspension 
containing approximately  106  CFU/ml in 3.2  ml of LB 
broth and incubated at 37 °C and counted following the 
above mentioned plating methods at 0, 24, 48 h and 72 h 
time points.
Cell adhesion assay
Adhesion of EHEC to INT-407 cell was performed fol-
lowing the method described previously [21, 24]. Briefly, 
INT-407 cell monolayers were pre-treated with 100  µl 
DMEM (control), different concentrations of BPEs 
(0.1 mg/ml GAE or 0.5 mg/ml GAE or 1.0 mg/ml GAE) 
or with probiotics or their CFCS in presence of different 
concentrations of BPEs (0.1  mg/ml GAE or 0.5  mg/ml 
GAE or 1.0 mg/ml GAE) for 1 h (triplicates). After pre-
treatment, 100  µl of EHEC, bacterial suspension with 
multiplicity of infection (MOI) of 10 (2 × 106  CFU/ml) 
were inoculated into each well, followed by 2 h incuba-
tion, lysis by 0.1% Triton X-100 for 15  min, serial dilu-
tions and plating for quantification.
Physiological properties of EHEC in the presence 
of probiotics or their CFCS and/or BPEs
Changes of physicochemical properties including cell 
surface hydrophobicity, auto-aggregation and injured cell 
ratio of EHEC were evaluated following the methodolo-
gies previously described [16] with modifications in cul-
ture condition. In brief, EHEC was grown in LB broth 
or LB broth with BPEs (0.1  mg/ml GAE or 0.5  mg/ml 
GAE or 1.0 mg/ml GAE) or CFCSs collected from Lc or 
Lc + CLA in combination with BPEs at 37 °C for 18 h.
EHEC biofilm formation
The ability of EHEC to form biofilms on glass surfaces 
in the absence or presence of CFCSs and/or BPEs was 
performed following the method previously described 
[16]. Briefly, 100  µl of EHEC, containing approximately 
5 × 105  CFU/ml, was inoculated in triplicate in wells of 
6-well plates (Corning, USA) containing 22 × 22  mm2 
glass slides. Wells containing LB broth (control) or LB 
broth supplemented with different concentrations of 
BPEs (0.1 mg/ml GAE or 0.5 mg/ml GAE or 1.0 mg/ml 
GAE), or CFCSs with BPEs were incubated for 48 with-
out shaking at 37  °C. Then, the glass slides were rinsed 
with PBS for five times and bacterial cells were recovered 
using sterile cell scraper (VWR, USA) from the glass sur-
face and enumerated.
RNA extraction, cDNA synthesis and quantitative RT-PCR 
assay
EHEC was grown in the absence or presence of BPEs 
(0.1 mg/ml GAE or 0.5 mg/ml GAE or 1.0 mg/ml GAE) 
or/and CFCSs collected from Lc or Lc + CLA and RNA 
was extracted according to the protocol of ZR Bacterial 
RNA MiniPrep kit (Zymo Research Corp., USA). The 
RNA quantification was carried out using NanoDrop 
spectrophotometer (Thermo Scientific Inc., USA) and 
cDNA synthesis was performed according to the proto-
col provided by Quanta Biosciences, USA. The custom-
synthesized oligonucleotide primers for espA, espB, 
espD, eaeA, ler, tir of EHEC were purchased from Euro-
fins MWG Operon, USA and methodology previously 
described [44] was followed to perform the qRT-PCR 
assay.
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Statistical analysis
Collected data were analyzed by the Statistical Analysis 
System software (SAS Institute Inc., USA). The one-way 
analysis of variance (ANOVA) for each single time point 
followed by Tukey’s test was used to evaluate the various 
treatments and significant differences among control and 
treatments were determined based on significant level of 
0.05.
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